Abstract P3-09-01: BRCAsearch - results of population-based screening of BRCA1 and BRCA2 germline mutations in incident breast cancer in South Sweden
Niklas Loman(Lund University), MP Nilsson(Lund University), Yvonne Brandberg(Karolinska Institutet), Barbro Silfverberg, Alexander Kvist(Lund University), Katharina Henriksson(Lund University), Åke Borg, Ulf Kristoffersson, Therese Törngren(Lund University)
Cited by 0
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
|The Lancet|2010|2.3k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
|Cancer Cell|2017|534